logo

For the Inventor, By the Inventor

London, United Kingdom

Gyroscope Therapeutics Limited


USPTO Granted Patents = 16



Trademarks = 6

Forward Citations = 11

Loading Chart...
Loading Chart...

61 inventors (with patents filed for the assignee):

goldMedal Michael F Keane (13 out of 31 patents)

silverMedal Benjamin L Ko (12 out of 19 patents)

bronzeMedal Isaac John Khan (12 out of 29 patents)

4.  Brendan J Oberkircher (11 out of 39 patents)

5.  Thomas Edward Meyer (10 out of 86 patents)

6.  Daniel W Price (9 out of 140 patents)

7.  Mark C Tsai (4 out of 8 patents)

8.  Geoffrey King (4 out of 5 patents)

9.  Daniel James Prenger (4 out of 17 patents)

10.  Robert H Roth (4 out of 46 patents)

11.  Michel Bruehwiler (3 out of 78 patents)

12.  Nathan Daniel Grubbs (3 out of 35 patents)

13.  Saeed Sokhanvar (3 out of 19 patents)

14.  Daniel J Yasevac (3 out of 17 patents)

15.  Leah R Soffer (3 out of 7 patents)


16 patents:

1. 12083042 - Guide apparatus for tangential entry into suprachoroidal space (2024-09-10),
2. 11998482 - Method and apparatus for subretinal administration of therapeutic agent (2024-06-04),
3. 11771834 - Dose clip assembly for syringe (2023-10-03),
4. 11759355 - Method of delivering leading blebs and agent to subretinal space (2023-09-19),
5. 11723798 - Sub-retinal tangential needle catheter guide and introducer (2023-08-15),
6. 11672696 - Therapeutic agent delivery device with convergent lumen (2023-06-13),
7. 11554042 - Method and apparatus for subretinal administration of therapeutic agent (2023-01-17),
8. 11338084 - Apparatus for subretinal administration of therapeutic agent via a curved needle (2022-05-24),
9. 11337852 - Therapeutic agent delivery device (2022-05-24),
10. 11273072 - Suprachoroidal injection device (2022-03-15),
11. 11076984 - Method of performing subretinal drainage and agent delivery (2021-08-03),
12. 11058576 - Method and apparatus for subretinal administration of therapeutic agent (2021-07-13),
13. 11000410 - Guide apparatus for tangential entry into suprachoroidal space (2021-05-11),
14. 10821021 - Sub-retinal tangential needle catheter guide and introducer (2020-11-03),
15. 10806630 - Injection device for subretinal delivery of therapeutic agent (2020-10-20),
Gyroscope Therapeutics Limited is a gene therapy company developing and commercializing transformative treatments for serious retinal diseases. They focus on delivering genetically-defined therapies to preserve and restore vision in patients. Their gene therapy platform utilizes adeno-associated virus (AAV) vectors to deliver genes to specific cells in the retina. Gyroscope is committed to transforming the lives of patients with retinal diseases through innovative gene therapies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#190 in London

#1,099 in United Kingdom

#36,634 in the World

...
London, United Kingdom

Gyroscope Therapeutics Limited

Forward Citations = 11

61 inventors:

goldMedal Michael F Keane (13 out of 31 patents)

silverMedal Benjamin L Ko (12 out of 19 patents)

bronzeMedal Isaac John Khan (12 out of 29 patents)

4.  Brendan J Oberkircher (11 out of 39 patents)

5.  Thomas Edward Meyer (10 out of 86 patents)

Please report any incorrect information to support@idiyas.com
Loading…